Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) can cure bone marrow failure in patients with Fanconi anemia (FA). Data on outcomes in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome (MDS), or acute leukemia have not been separately analyzed. PATIENT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ayas, Mouhab, Saber, Wael, Davies, Stella M., Harris, Richard E., Hale, Gregory A., Socie, Gerard, LeRademacher, Jennifer, Thakar, Monica, Deeg, H. Joachim J., Al-Seraihy, Amal, Battiwalla, Minoo, Camitta, Bruce M., Olsson, Richard, Bajwa, Rajinder S., Bonfim, Carmem M., Pasquini, Ricardo, MacMillan, Margaret L., George, Biju, Copelan, Edward A., Wirk, Baldeep, Al Jefri, Abdullah, Fasth, Anders L., Guinan, Eva C., Horn, Biljana N., Lewis, Victor A., Slavin, Shimon, Stepensky, Polina, Bierings, Marc, Gale, Robert Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2013
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3635221/
https://ncbi.nlm.nih.gov/pubmed/23547077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.45.9719
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi